Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.24(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1671
+0.0019(+0.16%)
GBP/USD
1.2572
+0.0026(+0.21%)
Bitcoin GBP
51,591.22
+855.28(+1.69%)

Meet one of the UK’s largest unknown start-ups

Video editing platform Veed has grown to 10 million users

AnaptysBio, Inc. (ANAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

26.58

+0.24

(+0.91%)

At close: 04:00PM EDT

26.75

+0.17

(+0.64%)

After hours:

04:03PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	726.13M
Enterprise value	353.04M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	41.71
Price/book (mrq)	8.24
Enterprise value/revenue	20.58
Enterprise value/EBITDA	-2.47

Trading information

Stock price history

Beta (5Y monthly)	-0.29
52-week change ³	24.48%
S&P500 52-week change ³	22.38%
52-week high ³	27.50
52-week low ³	13.36
50-day moving average ³	22.97
200-day moving average ³	20.17

Share statistics

Avg vol (3-month) ³	364.73k
Avg vol (10-day) ³	519.2k
Shares outstanding ⁵	27.32M
Implied shares outstanding ⁶	26.76M
Float ⁸	14.98M
% held by insiders ¹	0.39%
% held by institutions ¹	114.41%
Shares short (15 Apr 2024) ⁴	4.27M
Short ratio (15 Apr 2024) ⁴	9.52
Short % of float (15 Apr 2024) ⁴	22.27%
Short % of shares outstanding (15 Apr 2024) ⁴	15.63%
Shares short (prior month 15 Mar 2024) ⁴	4.14M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-386.41%

Management effectiveness

Return on assets (ttm)	-18.47%
Return on equity (ttm)	-93.44%

Income statement

Revenue (ttm)	17.16M
Revenue per share (ttm)	0.64
Quarterly revenue growth (yoy)	32.30%
Gross profit (ttm)	N/A
EBITDA	-156.42M
Net income avi to common (ttm)	-163.62M
Diluted EPS (ttm)	-6.08
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	390.9M
Total cash per share (mrq)	14.61
Total debt (mrq)	328.62M
Total debt/equity (mrq)	373.00%
Current ratio (mrq)	10.87
Book value per share (mrq)	3.31

Cash flow statement

Operating cash flow (ttm)	-120.8M
Levered free cash flow (ttm)	-73.42M